Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands

por Al, Maiwenn J, Hakkaart, Leona, Tan, Siok Swan, Bakker, Jan
Publicado 2010

The increasing importance of a continence nurse specialist to improve outcomes and save costs of urinary incontinence care: an analysis of future policy scenarios

por Franken, Margreet G, Corro Ramos, Isaac, Los, Jeanine, Al, Maiwenn J
Publicado 2018

Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine

por Mandrik, Olena, Corro Ramos, Isaac, Knies, Saskia, Al, Maiwenn, Severens, Johan L
Publicado 2015

Association between lung function and exacerbation frequency in patients with COPD

por Hoogendoorn, Martine, Feenstra, Talitha L, Hoogenveen, Rudolf T, Al, Maiwenn, Mölken, Maureen Rutten-van
Publicado 2010

Home Telemonitoring and a Diagnostic Algorithm in the Management of Heart Failure in the Netherlands: Cost-effectiveness Analysis

por Albuquerque de Almeida, Fernando, Corro Ramos, Isaac, Al, Maiwenn, Rutten-van Mölken, Maureen
Publicado 2022

Real‐world evidence in health technology assessment of high‐risk medical devices: Fit for purpose?

por Klein, Philip, Blommestein, Hedwig, Al, Maiwenn, Pongiglione, Benedetta, Torbica, Aleksandra, de Groot, Saskia
Publicado 2022

Mix and match. A simulation study on the impact of mixed-treatment comparison methods on health-economic outcomes

por Vemer, Pepijn, Al, Maiwenn J., Oppe, Mark, Rutten-van Mölken, Maureen P. M. H.
Publicado 2017

TECH-VER: A Verification Checklist to Reduce Errors in Models and Improve Their Credibility

por Büyükkaramikli, Nasuh C., Rutten-van Mölken, Maureen P. M. H., Severens, Johan L., Al, Maiwenn
Publicado 2019

First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis

por Holleman, Marscha S, van Tinteren, Harm, Groen, Harry JM, Al, Maiwenn J, Uyl-de Groot, Carin A
Publicado 2019

Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with non-small cell lung cancer harbouring EGFR mutations

por Holleman, Marscha S., Al, Maiwenn J., Zaim, Remziye, Groen, Harry J. M., Uyl-de Groot, Carin A.
Publicado 2019

Impact of hospitalisation on health-related quality of life in patients with chronic heart failure

por Albuquerque de Almeida, Fernando, Al, Maiwenn J., Koymans, Ron, Riistama, Jarno, Pauws, Steffen, Severens, Johan L.
Publicado 2020

Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia

por Vreman, Rick A., Geenen, Joost W., Hövels, Anke M., Goettsch, Wim G., Leufkens, Hubert G. M., Al, Maiwenn J.
Publicado 2019

The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling

por van Voorn, George A. K., Vemer, Pepijn, Hamerlijnck, Dominique, Ramos, Isaac Corro, Teunissen, Geertruida J., Al, Maiwenn, Feenstra, Talitha L.
Publicado 2015

Economic evaluation alongside a single RCT of an integrative psychotherapeutic nursing home programme

por Hakkaart-van Roijen, Leona, Bakker, Ton JEM, Al, Maiwenn, van der Lee, Jacqueline, Duivenvoorden, Hugo J, Ribbe, Miel W, Huijsman, Robbert
Publicado 2013

Use of Value of Information in Healthcare Decision Making: Exploring Multiple Perspectives

por Bindels, Jill, Ramaekers, Bram, Ramos, Isaac Corro, Mohseninejad, Leyla, Knies, Saskia, Grutters, Janneke, Postma, Maarten, Al, Maiwenn, Feenstra, Talitha, Joore, Manuela
Publicado 2015

Cardiovascular risk factor management in patients with RA compared to matched non-RA patients

por Alemao, Evo, Cawston, Helene, Bourhis, Francois, Al, Maiwenn, Rutten-van Mölken, Maureen P. M. H., Liao, Katherine P., Solomon, Daniel H.
Publicado 2016

Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research

por van Asselt, Thea, Ramaekers, Bram, Corro Ramos, Isaac, Joore, Manuela, Al, Maiwenn, Lesman-Leegte, Ivonne, Postma, Maarten, Vemer, Pepijn, Feenstra, Talitha
Publicado 2017

Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a...

por Büyükkaramikli, Nasuh C., de Groot, Saskia, Riemsma, Rob, Fayter, Debra, Armstrong, Nigel, Portegijs, Piet, Duffy, Steven, Kleijnen, Jos, Al, Maiwenn J.
Publicado 2018

Lenalidomide for the Treatment of Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated with Deletion 5q Cytogenetic Abnormality: An Evidence Review of the NICE Submissi...

por Blommestein, Hedwig M., Armstrong, Nigel, Ryder, Steve, Deshpande, Sohan, Worthy, Gill, Noake, Caro, Riemsma, Rob, Kleijnen, Jos, Severens, Johan L., Al, Maiwenn J.
Publicado 2015

Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE...

por Büyükkaramikli, Nasuh C., Blommestein, Hedwig M., Riemsma, Rob, Armstrong, Nigel, Clay, Fiona. J., Ross, Janine, Worthy, Gill, Severens, Johan, Kleijnen, Jos, Al, Maiwenn J.
Publicado 2017